HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

World’s First COVID-19 Vaccine to Be Launched by Russia on August 10-12

By HospiMedica International staff writers
Posted on 31 Jul 2020
Illustration
Illustration
Russia is all set to register a coronavirus vaccine by August 10-12, paving the way for what would be the first official approval of an inoculation against COVID-19 in the world, according to a Bloomberg report.

In a recent televised meeting of officials with Russian President Vladimir Putin, the country’s Deputy Prime Minister Tatyana Golikova said that the vaccine was expected to receive conditional registration in August and production was likely to begin in September. The vaccine developed by the Gamalei Institute of Epidemiology and Microbiology (Moscow, Russia) could be approved for civilian use within three to seven days of its registration, said a person familiar with the process to Bloomberg.

Russia’s COVID-19 vaccine is scheduled to enter Phase 3 trials in Russia, Saudi Arabia and the United Arab Emirates. Despite its developers claiming the vaccine to be safe and potentially the first to be administered to the public, there is concern over the absence of published data and its fast paced development. Russian health professionals will be administered the COVID19 vaccine before the completion of its clinical trials, according to the Bloomberg report. Russia is also conducting clinical trials of a second COVID19 vaccine, while two more vaccines are expected to be soon granted permission for testing.

“The key requirements for a vaccine are its proven effectiveness and safety so everything needs to be done very carefully and accurately,” Putin reportedly said at the end of the meeting with officials. “Our confidence in the vaccine must be absolute.”

Related Links:
Gamalei Institute of Epidemiology and Microbiology

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Half Apron
Demi
Ultrasound Needle Guidance System
SonoSite L25

Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more